TAM
DYN icon

TFG Asset Management’s Dyne Therapeutics DYN Stock Holding History

TFG Asset Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.68M Buy
258,132
+10,135
+4% +$175K 0.91% 19
2025
Q4 		$4.85M Buy
247,997
+24,816
+11% +$470K 1.02% 13
2025
Q3 		$2.82M Buy
223,181
+84,806
+61% +$967K 0.38% 26
2025
Q2 		$1.32M Buy
+138,375
New +$1.52M 0.21% 30

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

TFG Asset Management's DYN Position: Q1 2026 in Review

TFG Asset Management increased its Dyne Therapeutics (DYN) stake by 4.1% in Q1 2026, buying an estimated $175K and bringing the position to 258,132 shares worth $4.68M. The position accounts for 0.91% of the portfolio, ranked #19.

TFG Asset Management first reported a position in DYN in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.85M in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • TFG Asset Management held 258,132 shares of Dyne Therapeutics worth $4.68M as of Q1 2026.
  • TFG Asset Management bought 10,135 Dyne Therapeutics shares in Q1 2026, an estimated $175K.
  • Dyne Therapeutics made up 0.91% of TFG Asset Management's portfolio in Q1 2026, its #19 holding.
  • TFG Asset Management first reported a position in Dyne Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • TFG Asset Management's Dyne Therapeutics position peaked at $4.85M in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on TFG Asset Management's 13F filing for Q1 2026, filed 15 May 2026.